Commission Implementing Regulation (EU) 2025/1513 of 28 July 2025 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use and the additional labelling requirements of the novel food Calanus finmarchicus oil

• CELEX: Implementing Regulation (EU) 2025/1513
• Articles: 4

Article 1

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

1.   Food supplements containing Calanus finmarchicus oil which were lawfully placed on the market before the date of entry into force of this Regulation may be marketed until their date of minimum durability or use by date.

2.   Food supplements containing Calanus finmarchicus oil which were dispatched from a third country and were on their way to the Union before the date of entry into force of this Regulation and complying with the rules in force before the date of entry into force of this Regulation may be marketed until their date of minimum durability or use by date.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:

(1)

in Table 1 (Authorised novel foods), the entry for ‘ Calanus finmarchicus  oil’ is replaced by the following:

Authorised novel food

Conditions under which the novel food may be used

Additional specific labelling requirements

Other requirements

‘

Calanus finmarchicus oil

Specified food category

Maximum levels

1.

The designation of the novel food on the labelling of the foodstuffs containing it shall be “oil from Calanus finmarchicus (crustacean)”.

2.

The labelling of food supplements containing Calanus finmarchicus oil shall bear a statement that those food supplements should not be consumed:

(a)

if other food supplements containing astaxanthin esters are consumed on the same day;

(b)

by infants and children younger than 3 years  / children under 10 years of age / children and adolescents under 14 years of age depending on the age groups the food supplement is intended for.’

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

0,9 g/day (≤ 2,25 mg astaxanthin per day) for the general population under 10 years of age, excluding infants and young children

2,2 g/day (≤ 5,5 mg astaxanthin per day) for the general population between 10 to 14 years of age

3,1 g/day (≤7,75 mg astaxanthin per day) for the general population older than 14 years of age